AbstractBackgroundIdentifying migraineurs by triptan utilization we studied risk for stroke in migraineurs compared to the general population.MethodsA cohort study including all citizens 25–80years of age in Denmark 2003–2011 was conducted. All persons prescribed triptans, and all those hospitalized for a first stroke were identified in the Danish Registries. Information on stroke severity/subtype and cardiovascular risk factors was available for stroke patients.FindingsOf the 49,711 patients hospitalized for a first stroke, 1084 were migraineurs using triptans. Adjusting for age, sex, income, and educational level, risk for stroke was higher among migraineurs in respect to all strokes (RR 1.07; CI 1.01–1.14) and ischemic strokes (RR 1.07; ...
Abstract Background Migraine has been associated with cardiovascular disease (CVD) events among midd...
Copyright © 2013 Halvor Øygarden et al. This is an open access article distributed under the Creativ...
Context Migraine is a kind of primary headache that affects 10% to 20% of people worldwide...
Background: The aim of our study was to evaluate the risk for comorbid cardio- and cerebrovascular d...
Objective. To examine the association between the cardiovascular (CV) risk factors and triptans use ...
Abstract Background The aim of our study was to evaluate the risk for comorbid cardio- and cerebrova...
The incidence of stroke, cardiovascular events, and death among 63,575 patients with migraine was co...
Migraine and stroke are two common and heterogeneous neurovascular disorders responsible for a signi...
Background. Migraine is prevalent in young patients and a frequent stroke mimic. To distinguish stro...
Background. Migraine is prevalent in young patients and a frequent stroke mimic. To distinguish stro...
Objective: Previous studies on the association between migraine and the risk of developing hemorrhag...
Background: Apart from the underlying cardiovascular (CV) risk associated with migraine, both tripta...
An association between migraine and ischemic events, especially ischemic stroke, has been debated fo...
Background: Stroke and migraine are 2 commonly found disorders that are scarcely linked together. Mi...
Background Safety concerns exist when using triptansto treat patients with cardiac contraindications...
Abstract Background Migraine has been associated with cardiovascular disease (CVD) events among midd...
Copyright © 2013 Halvor Øygarden et al. This is an open access article distributed under the Creativ...
Context Migraine is a kind of primary headache that affects 10% to 20% of people worldwide...
Background: The aim of our study was to evaluate the risk for comorbid cardio- and cerebrovascular d...
Objective. To examine the association between the cardiovascular (CV) risk factors and triptans use ...
Abstract Background The aim of our study was to evaluate the risk for comorbid cardio- and cerebrova...
The incidence of stroke, cardiovascular events, and death among 63,575 patients with migraine was co...
Migraine and stroke are two common and heterogeneous neurovascular disorders responsible for a signi...
Background. Migraine is prevalent in young patients and a frequent stroke mimic. To distinguish stro...
Background. Migraine is prevalent in young patients and a frequent stroke mimic. To distinguish stro...
Objective: Previous studies on the association between migraine and the risk of developing hemorrhag...
Background: Apart from the underlying cardiovascular (CV) risk associated with migraine, both tripta...
An association between migraine and ischemic events, especially ischemic stroke, has been debated fo...
Background: Stroke and migraine are 2 commonly found disorders that are scarcely linked together. Mi...
Background Safety concerns exist when using triptansto treat patients with cardiac contraindications...
Abstract Background Migraine has been associated with cardiovascular disease (CVD) events among midd...
Copyright © 2013 Halvor Øygarden et al. This is an open access article distributed under the Creativ...
Context Migraine is a kind of primary headache that affects 10% to 20% of people worldwide...